FDA Bars Drug Importer for Five Years Over Bad Labels
Published Date: 9/19/2025
Notice
Summary
William Goldsmith is banned for 5 years from importing any drugs into the U.S. because he was convicted of selling mislabeled drugs. He didn’t respond to the FDA’s notice or ask for a hearing, so the ban is official starting August 19, 2025. This means no drug imports from him for half a decade, protecting consumers from unsafe products.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Individual banned from importing drugs
William Goldsmith is barred for 5 years from importing or offering for import any drug into the United States, effective August 19, 2025. FDA based the order on his conviction of one felony count for introducing misbranded drugs into interstate commerce. Mr. Goldsmith did not respond to the FDA's notice or request a hearing, and his failure to respond waived his right to a hearing.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16959, Frequently Asked Questions-Developing Potential Cellular and Gene Therapy Products; Final Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance titled "Frequently asked Questions--Developing Potential Cellular and Gene Therapy Products." The guidance document provides industry with answers to frequently asked questions (FAQs) and commonly faced issues that arise during the development of cellular and gene therapy (CGT) products. The FAQs represent common questions directed to the Agency and span multiple disciplines, including regulatory review; chemistry, manufacturing, and controls (CMC); pharmacology/toxicology; clinical; and clinical pharmacology. This guidance announced in this notice finalizes the draft guidance of the same title issued on November 19, 2024.
2026-16939, GNT USA, LLC.; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC., c/o Exponent, Inc., proposing that we amend our color additive regulations to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a color additive in various foods at levels consistent with good manufacturing practices.
2026-16942, Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate
The Food and Drug Administration (FDA, we, or the Agency) is amending the regulations for food additives permitted in feed and drinking water of animals to provide for the safe use of chromium DL- methionine chelate as a nutritional source of chromium in cattle feed. This action is in response to a food additive petition filed by Zinpro Corp.
Previous / Next Documents
Previous: 2025-18212, Agency Information Collection Activities; Submission for OMB Review; Comment Request, Employment Transition Models Demonstration and Evaluation, New Collection
The Department of Labor is asking for feedback on a new survey about how people move from one job to another. This helps make sure the questions are clear and don’t take too much time or money to answer. If you’re involved in job programs or studies, your input matters before the final rules are set.
Next: 2025-18214, Formations of, Acquisitions by, and Mergers of Bank Holding Companies
Big banks like PNC want to buy or merge with other banks, like FirstBank in Colorado. The Federal Reserve is checking these deals to make sure they follow the rules and wants your comments by October 20, 2025. These changes could shake up who controls local banks and might affect how money moves around.